StockData
LMRINasdaqServices-Medical LaboratoriesFiscal year ends December 31

Lumexa Imaging Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$10.72−0.06 (-0.56%)

Close on Oct 19, 2026

Market cap
$1.03B
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 12, 2026During market hours$264.20M$0.03$0.20
Q1 FY2026
Ended Mar 31, 2026
May 12, 2026During market hours$252.50M$0.02$0.18
Q4 FY2025
Ended Dec 31, 2025
Mar 2, 2026Before market open$261.00M––

Company guidance

Outlook given with results on Aug 12, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
Adjusted EBITDAnon-GAAPfull-year 2026$235.00M to $241.00MNarrowed
Adjusted EPSnon-GAAP2026$0.71 to $0.77Maintained
consolidated revenuefull-year 2026$1.05B to $1.10BMaintained

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Lumexa Imaging filed with the SEC